Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions
Clinical trial NCT00833664 · COMPLETED
Trial details
- NCT number
- NCT00833664
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2002-01-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.